Hopkinson Craig C.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$6.29M

Insider Activity of Hopkinson Craig C.

According to the SEC Form 4 filings, Hopkinson Craig C., being in a position of

  1. EVP R&D, Chief Medical Officer at Alkermes plc,
    оver the last 12 months, has bought 0 shares, and sold 154188 shares for $4.78M,
    over all time since 2021-04-15, has bought 0 shares, and sold 227199 shares for $6.29M.

The largest sale of all time was on 2024-12-09 and amounted to 61151 share of Alkermes plc for $1.96M.

Biography of Hopkinson Craig C.

No biography is available at this moment.

2024-12-09SaleAlkermes plc
ALKS
EVP R&D, Chief Medical Officer
61,151
0.0384%
$32.07$1.96M-2.41%
2024-12-05SaleAlkermes plc
ALKS
EVP R&D, Chief Medical Officer
9,221
0.0058%
$31.50$290,462-1.78%
2024-12-04SaleAlkermes plc
ALKS
EVP R&D, Chief Medical Officer
14,349
0.0088%
$30.77$441,550-1.26%
2024-11-11SaleAlkermes plc
ALKS
EVP R&D, Chief Medical Officer
58,996
0.0363%
$30.08$1.77M-1.96%
2024-11-06SaleAlkermes plc
ALKS
EVP R&D, Chief Medical Officer
10,471
0.0065%
$29.53$309,169+0.65%
2022-02-23SaleAlkermes plc
ALKS
EVP R&D, Chief Medical Officer
11,983
0.0076%
$24.76$296,650+8.25%
2022-02-18SaleAlkermes plc
ALKS
EVP R&D, Chief Medical Officer
2,306
0.0014%
$25.17$58,042+4.03%
2021-06-09SaleAlkermes plc
ALKS
EVP R&D, Chief Medical Officer
882
0.0005%
$24.60$21,697+5.67%
2021-04-15SaleAlkermes plc
ALKS
EVP R&D, Chief Medical Officer
57,840
0.0359%
$19.72$1.14M+25.14%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.